# FDA 483 - Fujifilm Corporation - September 22, 2023

Source: https://www.globalkeysolutions.net/records/483/fujifilm-corporation/e6d1516f-a0ee-4183-b144-fb1dd013eafa

> FDA 483 for Fujifilm Corporation on September 22, 2023. Product: device. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Fujifilm Corporation
- Inspection Date: 2023-09-22
- Product Type: device
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Documents

- [483 - 2018-07-09](https://www.globalkeysolutions.net/records/483/fujifilm-corporation/a37bacb3-6491-4db0-a771-908cc8977b50)
- [483 - 2023-09-22](https://www.globalkeysolutions.net/records/483/fujifilm-corporation/9bf1be1e-de1e-4b86-ae30-1f925478991e)
- [WARNING_LETTER - Unknown Date](https://www.globalkeysolutions.net/records/warning_letter/fujifilm-corporation/e31c55c2-c214-4c62-b4e8-7aca917f216f)
- [483 - 2018-07-13](https://www.globalkeysolutions.net/records/483/fujifilm-corporation/e3852ef6-6cd1-403b-9ba1-eeca4150adb4)

## Related Officers

- [Thai T. Duong](https://www.globalkeysolutions.net/people/thai-t-duong/59737092-2f30-43a7-b23b-36fa7f212c4a)

Company: https://www.globalkeysolutions.net/companies/fujifilm-corporation/6310bc48-89ef-4f36-98c9-1e0294a89e06

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd